ASCLF
Price:
$1.205
Market Cap:
$8.99B
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company's commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an o...[Read more]
Industry
Biotechnology
IPO Date
2019-11-19
Stock Exchange
OTC
Ticker
ASCLF
According to Ascletis Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.55B. This represents a change of 72.92% compared to the average of 4.36B of the last 4 quarters.
The mean historical Enterprise Value of Ascletis Pharma Inc. over the last ten years is 4.13B. The current 7.55B Enterprise Value has changed 18.16% with respect to the historical average. Over the past ten years (40 quarters), ASCLF's Enterprise Value was at its highest in in the June 2017 quarter at 14.04B. The Enterprise Value was at its lowest in in the December 2020 quarter at -195984355.22.
Average
4.13B
Median
1.83B
Minimum
-192427209.33
Maximum
13.62B
Discovering the peaks and valleys of Ascletis Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 364.81%
Maximum Annual Enterprise Value = 13.62B
Minimum Annual Increase = -332.90%
Minimum Annual Enterprise Value = -192427209.33
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 8.51B | 331.25% |
| 2024 | 1.97B | 109.15% |
| 2023 | 943.53M | -54.71% |
| 2022 | 2.08B | 364.81% |
| 2021 | 448.16M | -332.90% |
| 2020 | -192427209.33 | 2.61% |
| 2019 | -187534024.49 | -111.13% |
| 2018 | 1.68B | -86.47% |
| 2017 | 12.45B | -8.60% |
The current Enterprise Value of Ascletis Pharma Inc. (ASCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.81B
5-year avg
2.79B
10-year avg
4.13B
Ascletis Pharma Inc.’s Enterprise Value is less than SanBio Company Limited (62.96B), greater than CStone Pharmaceuticals (6.13B), greater than Pharming Group N.V. (727.15M), greater than Idorsia Ltd (2.82B), less than Paramount Bed Holdings Co., Ltd. (170.12B), less than SSY Group Limited (9.24B), less than BioGaia AB (publ) (10.61B), less than Tobii Dynavox AB (publ) (8.90B), less than Life Healthcare Group Holdings Limited (20.17B), greater than Valneva SE (527.34M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 62.96B | $1.28B | |
| 6.13B | $1.14B | |
| 727.15M | $920.12M | |
| 2.82B | $1.77B | |
| 170.12B | $1.15B | |
| 9.24B | $1.19B | |
| 10.61B | $1.25B | |
| 8.90B | $803.97M | |
| 20.17B | $983.83M | |
| 527.34M | $460.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascletis Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ascletis Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ascletis Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
What is the 3-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
What is the 5-year average Enterprise Value for Ascletis Pharma Inc. (ASCLF)?
How does the current Enterprise Value for Ascletis Pharma Inc. (ASCLF) compare to its historical average?